• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒长度及其与韩国人群慢性淋巴细胞白血病基因突变的相关性。

Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population.

机构信息

Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.

Department of Laboratory Medicine, Chung-Ang University Hospital, Seoul, Korea.

出版信息

PLoS One. 2019 Jul 23;14(7):e0220177. doi: 10.1371/journal.pone.0220177. eCollection 2019.

DOI:10.1371/journal.pone.0220177
PMID:31335885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6650075/
Abstract

Telomere length (TL) is a prognostic indicator in Caucasian chronic lymphocytic leukemia (CLL), but its significance in Asian CLL remains unknown. To investigate the prognostic significance of TL and its correlation with cytogenetic aberrations and somatic mutations, we analyzed TL measurements at the cellular level by interphase fluorescence in situ hybridization in patients with CLL in Korea. The present study enrolled 110 patients (41 females and 69 males) diagnosed with CLL according to the World Health Organization criteria (2001-2017). TLs of bone marrow nucleated cells at the single-cell level were measured by quantitative fluorescence in situ hybridization (Q-FISH) in 71 patients. The correlations of TL with clinical characteristics, cytogenetic aberrations, genetic mutations, and overall survival were assessed. The median value of mean TL in CLL patients (T/C ratio 7.46 (range 1.19-18.14) was significantly shorter than that in the normal controls (T/C ratio 15.28 (range 8.59-24.93) (p < 0.001). Shorter TLs were associated with complex karyotypes (p = 0.030), del(11q22) (p = 0.023), presence of deletion and/or mutation in ATM and/or TP53 (p = 0.019), and SH2B3 mutation (p = 0.015). A shorter TL was correlated with lower hemoglobin levels and adverse survival (mean TL < 9.35, p = 0.021). When the proportion of cells with extremely short TLs (< 7.61) was greater than 90%, CLL patients showed poor survival (p = 0.002). Complex karyotypes, TP53 mutation, and the number of mutated genes were determined to be significant adverse variables by multivariable Cox analysis (p = 0.011, p = 0.002, and p = 0.002, respectively). TL was attrited in CLL, and attrited telomeres were correlated with adverse survival and other well-known adverse prognostic factors. We infer that TL is an independent adverse prognostic predictor in Korean CLL.

摘要

端粒长度 (TL) 是高加索人群慢性淋巴细胞白血病 (CLL) 的预后指标,但在亚洲人群 CLL 中的意义尚不清楚。为了研究 TL 的预后意义及其与细胞遗传学异常和体细胞突变的相关性,我们在韩国对 CLL 患者进行了细胞间荧光原位杂交 (FISH) 的 TL 测量。本研究共纳入 110 名患者(女性 41 名,男性 69 名),根据世界卫生组织标准(2001-2017 年)诊断为 CLL。在 71 名患者中通过定量荧光原位杂交 (Q-FISH) 测量骨髓有核细胞的 TL。评估 TL 与临床特征、细胞遗传学异常、基因突变和总生存的相关性。CLL 患者的平均 TL 中位数(T/C 比值 7.46(范围 1.19-18.14)明显短于正常对照(T/C 比值 15.28(范围 8.59-24.93)(p<0.001)。较短的 TL 与复杂核型(p=0.030)、del(11q22)(p=0.023)、ATM 和/或 TP53 缺失和/或突变(p=0.019)以及 SH2B3 突变(p=0.015)相关。较短的 TL 与较低的血红蛋白水平和不良生存相关(平均 TL<9.35,p=0.021)。当极短 TL 细胞比例 (>90%)时,CLL 患者的生存状况较差(p=0.002)。多变量 Cox 分析显示,复杂核型、TP53 突变和突变基因数量是显著的不良变量(p=0.011、p=0.002 和 p=0.002)。TL 在 CLL 中耗竭,耗竭的端粒与不良生存和其他已知的不良预后因素相关。我们推断 TL 是韩国 CLL 的独立不良预后预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/838ff83a3bfa/pone.0220177.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/f15766e3e03d/pone.0220177.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/3f6d595a9ed0/pone.0220177.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/309d4ca5adb9/pone.0220177.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/7818af3f514a/pone.0220177.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/c8912d1b217c/pone.0220177.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/838ff83a3bfa/pone.0220177.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/f15766e3e03d/pone.0220177.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/3f6d595a9ed0/pone.0220177.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/309d4ca5adb9/pone.0220177.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/7818af3f514a/pone.0220177.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/c8912d1b217c/pone.0220177.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/717f/6650075/838ff83a3bfa/pone.0220177.g006.jpg

相似文献

1
Telomere length and its correlation with gene mutations in chronic lymphocytic leukemia in a Korean population.端粒长度及其与韩国人群慢性淋巴细胞白血病基因突变的相关性。
PLoS One. 2019 Jul 23;14(7):e0220177. doi: 10.1371/journal.pone.0220177. eCollection 2019.
2
Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients.端粒较短与新诊断的慢性淋巴细胞白血病患者的 NOTCH1/SF3B1/TP53 异常和不良预后相关。
Am J Hematol. 2013 Aug;88(8):647-51. doi: 10.1002/ajh.23466. Epub 2013 Jun 20.
3
Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.端粒缩短、TP53突变以及慢性淋巴细胞白血病中的缺失会导致染色体不稳定性增加以及异染色质区域的断点聚集。
Ann Hematol. 2017 Sep;96(9):1493-1500. doi: 10.1007/s00277-017-3055-1. Epub 2017 Jul 9.
4
Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.端粒缩短与慢性淋巴细胞白血病中基因组复杂性增加相关。
Tumour Biol. 2015 Nov;36(11):8317-24. doi: 10.1007/s13277-015-3556-2. Epub 2015 May 26.
5
Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.ATM和TP53缺失在中国慢性淋巴细胞白血病患者中的预后意义
Leuk Res. 2008 Jul;32(7):1071-7. doi: 10.1016/j.leukres.2007.10.009. Epub 2007 Nov 26.
6
Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.骨髓增生异常综合征中短端粒长度及其与基因突变的相关性。
J Hematol Oncol. 2016 Jul 28;9(1):62. doi: 10.1186/s13045-016-0287-9.
7
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.慢性淋巴细胞白血病诊断时的广泛二代测序分析:临床与生物学相关性
J Hematol Oncol. 2016 Sep 15;9(1):88. doi: 10.1186/s13045-016-0320-z.
8
Telomere status in chronic lymphocytic leukemia with TP53 disruption.伴有TP53基因破坏的慢性淋巴细胞白血病中的端粒状态
Oncotarget. 2016 Aug 30;7(35):56976-56985. doi: 10.18632/oncotarget.10927.
9
Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence.韩国慢性淋巴细胞白血病患者中西方常见复发性染色体畸变的验证,发病率极低。
Hematol Oncol. 2014 Dec;32(4):169-77. doi: 10.1002/hon.2103. Epub 2013 Oct 7.
10
Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome.高危慢性淋巴细胞白血病的端粒长度:与疾病特征及预后的关联
Leuk Lymphoma. 2018 Jul;59(7):1614-1623. doi: 10.1080/10428194.2017.1390236. Epub 2017 Oct 24.

引用本文的文献

1
The Telomere Length Signature in Leukemias-From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase.白血病中的端粒长度特征——从端粒缩短的分子机制到针对端粒酶的免疫治疗选择
Cancers (Basel). 2025 Jun 10;17(12):1936. doi: 10.3390/cancers17121936.
2
Causal effect between telomere length and thirteen types of cancer in Asian population: a bidirectional Mendelian randomization study.亚洲人群端粒长度与13种癌症之间的因果关系:一项双向孟德尔随机化研究
Aging Clin Exp Res. 2025 Apr 29;37(1):134. doi: 10.1007/s40520-025-03046-z.
3
Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype.

本文引用的文献

1
Are clonal cells circulating in the peripheral blood of myelodysplastic syndrome?: Quantitative comparison between bone marrow and peripheral blood by targeted gene sequencing and fluorescence in situ hybridization.克隆细胞是否在骨髓增生异常综合征患者的外周血中循环?:通过靶向基因测序和荧光原位杂交对骨髓和外周血进行定量比较。
Leuk Res. 2018 Aug;71:92-94. doi: 10.1016/j.leukres.2018.07.007. Epub 2018 Jul 10.
2
Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.端粒和端粒酶在造血功能障碍中的作用:预后意义和药物干预。
Int J Mol Sci. 2017 Oct 28;18(11):2267. doi: 10.3390/ijms18112267.
3
伴有复杂核型的慢性淋巴细胞白血病患者的管理策略
Br J Haematol. 2025 Mar;206(3):832-841. doi: 10.1111/bjh.19986. Epub 2025 Jan 6.
4
Genetically determined telomere length as a risk factor for hematological malignancies: evidence from Mendelian randomization analysis.遗传决定的端粒长度作为血液系统恶性肿瘤的风险因素:来自孟德尔随机分析的证据。
Aging (Albany NY). 2024 Mar 6;16(5):4684-4698. doi: 10.18632/aging.205625.
5
Role of telomere length in human carcinogenesis (Review).端粒长度在人类肿瘤发生中的作用(综述)。
Int J Oncol. 2023 Jul;63(1). doi: 10.3892/ijo.2023.5526. Epub 2023 May 26.
6
Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability.慢性淋巴细胞白血病中的染色体碎裂:基因组不稳定的驱动因素
Front Oncol. 2021 Nov 26;11:771664. doi: 10.3389/fonc.2021.771664. eCollection 2021.
7
Telomere Dysfunction in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中的端粒功能障碍
Front Oncol. 2021 Jan 15;10:612665. doi: 10.3389/fonc.2020.612665. eCollection 2020.
Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of deletions.
伴有复杂核型的慢性淋巴细胞白血病患者即使没有缺失也显示出不良预后。
Oncotarget. 2017 Apr 21;8(33):54297-54303. doi: 10.18632/oncotarget.17350. eCollection 2017 Aug 15.
4
Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.端粒缩短、TP53突变以及慢性淋巴细胞白血病中的缺失会导致染色体不稳定性增加以及异染色质区域的断点聚集。
Ann Hematol. 2017 Sep;96(9):1493-1500. doi: 10.1007/s00277-017-3055-1. Epub 2017 Jul 9.
5
Prognostic role of telomere length in malignancies: A meta-analysis and meta-regression.端粒长度在恶性肿瘤中的预后作用:一项荟萃分析和元回归分析
Exp Mol Pathol. 2017 Jun;102(3):455-474. doi: 10.1016/j.yexmp.2017.05.010. Epub 2017 May 12.
6
Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing.通过靶向测序确定的韩国慢性淋巴细胞白血病的基因组图谱。
PLoS One. 2016 Dec 13;11(12):e0167641. doi: 10.1371/journal.pone.0167641. eCollection 2016.
7
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.国际慢性淋巴细胞白血病预后指数(CLL-IPI):个体患者数据的荟萃分析。
Lancet Oncol. 2016 Jun;17(6):779-790. doi: 10.1016/S1470-2045(16)30029-8. Epub 2016 May 13.
8
Chronic lymphocytic leukemia: a clinical review including Korean cohorts.慢性淋巴细胞白血病:一项包括韩国队列的临床综述
Korean J Intern Med. 2016 May;31(3):433-43. doi: 10.3904/kjim.2015.074. Epub 2016 Apr 5.
9
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.慢性淋巴细胞白血病中克隆性和亚克隆性TP53、SF3B1、BIRC3、NOTCH1和ATM突变的临床影响
Blood. 2016 Apr 28;127(17):2122-30. doi: 10.1182/blood-2015-07-659144. Epub 2016 Feb 2.
10
Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.慢性淋巴细胞白血病中携带NOTCH1、SF3B1或BIRC3突变的小亚克隆的临床影响
Haematologica. 2016 Apr;101(4):e135-8. doi: 10.3324/haematol.2015.136051. Epub 2016 Jan 27.